Apply for Behavioral Research Grants

If you are interested in grants for behavioral research in cancer prevention and control, review this selection of funding opportunity announcements.


Apply for Funding

Title Announcement # Expiration Date Contact
Modular R01s in Cancer Control and Population Sciences

Helpful Resources
PAR-18-869 (R01 Clinical Trial Optional) March 9, 2021 Scott Rogers
240-276-6932
rogerssc@mail.nih.gov
Academic Research Enhancement Award PA-18-343 (R15 Clinical Trial Required) January 8, 2021 April Oh
240-276-6709
april.oh@nih.gov
Cancer Prevention and Control Clinical Trials Grant Program PAR-18-559 (R01 Clinical Trial Required) January 8, 2021 Susan Czajkowski
240-276-5871
czajkows@mail.nih.gov
NCI Small Grants Program for Cancer Research (NCI Omnibus) PAR-18-021 (R03 Clinical Trial Optional) January 8, 2020 Gina Tesauro
240-276-6786
gina.tesauro@nih.gov
NIH Research Project Grant PA-16-160 (R01) May 8, 2019 View the BRP staff directory to identify Program Directors by research area and Branch assignment

See information about NCI Small Grants Program for Cancer Research (NCI Omnibus) and NIH Research Project Grants

Title Announcement # Expiration Date Contact
Oral Anticancer Agents: Utilization, Adherence, and Health Care Delivery

Helpful Resources
PA-18-004 (R01 Clinical Trial Optional)
PA-18-014 (R21 Clinical Trial Optional)
January 8, 2020 Wendy Nelson
240-276-6971
nelsonw@mail.nih.gov
Fundamental Mechanisms of Affective and Decisional Processes in Cancer Control PAR-18-681 (R01 Clinical Trial Optional) October 12, 2019 Rebecca Ferrer
301-852-1167
rebecca.ferrer@nih.gov
Perception and Cognition Research to Inform Cancer Image Interpretation

Helpful Resources
PAR-18-640 (R01 Clinical Trial Optional)
PAR-18-641 (R21 Clinical Trial Optional)
September 27, 2019 Todd Horowitz
240-276-6963
horowitzts@mail.nih.gov
Neural Regulation of Cancer PAR-16-245 (R01)
PAR-16-246 (R21)
June 28, 2019 Paige Green
240-276-6899
paige.green@nih.gov
Cancer-related Behavioral Research through Integrating Existing Data

Helpful Resources
PAR-16-256 (R01)
PAR-16-255 (R21)
June 15, 2019 Richard Moser
240-276-6915
moserr@mail.nih.gov
Leveraging Cognitive Neuroscience Research to Improve Assessment of Cancer Treatment Related Cognitive Impairment

Helpful Resources
PAR-18-605 (R01 Clinical Trial Optional)
PAR-18-606 (R21 Clinical Trial Optional)
April 12, 2019 Jerry Suls
240-276-6811
jerry.suls@nih.gov
Predicting Behavioral Responses to Population-Level Cancer Control Strategies

Helpful Resources
PAR-18-024 (R21 Clinical Trial Optional) April 12, 2019 Rebecca Ferrer
301-852-1167
rebecca.ferrer@nih.gov
Communication and Decision Making for Individuals with Inherited Cancer Syndromes RFA-CA-19-001 (U01 Clinical Trial Optional) January 10, 2019 Wendy Nelson
240-276-6971
nelsonw@mail.nih.gov
Research on the Mechanisms and/or Behavioral Outcomes of Multisensory Processing PA-18-545 (R01 Clinical Trial Optional) January 8, 2019 Todd Horowitz
240-276-6963
horowitzts@mail.nih.gov
Education and Health: New Frontiers PAR-18-387 (R01 Clinical Trial Optional)
PAR-18-388 (R03 Clinical Trial Optional)
PAR-18-362 (R21 Clinical Trial Optional)
January 8, 2019 Todd Horowitz
240-276-6963
horowitzts@mail.nih.gov

See information about NCI Small Grants Program for Cancer Research (NCI Omnibus) and NIH Research Project Grants

Title Announcement # Expiration Date Contact
Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival PAR-18-893 (R01 Clinical Trial Optional)
PAR-18-892 (R21 Clinical Trial Optional)
September 8, 2021 Frank Perna
240-276-6782
pernafm@mail.nih.gov
Time-Sensitive Obesity Policy and Program Evaluation PAR-18-854 (R01 Clinical Trial Not Allowed) September 11, 2021 David Berrigan
240-276-6752 berrigad@mail.nih.gov
Age-related Microbiota Changes and their Implications in Chronic Disease Prevention, Treatment and Progression

PA-18-738 (R01 Clinical Trial Optional)
PA-18-739 (R21 Clinical Trial Optional) 

May 8, 2021 Tanya Agurs-Collins
240-276-6956
collinsta@mail.nih.gov
Exploratory/Developmental Clinical Research Grants in Obesity PA-18-720 (R21 Clinical Trial Optional) May 8, 2021 Tanya Agurs-Collins
240-276-6956
collinsta@mail.nih.gov
Testing Interventions for Health-Enhancing Physical Activity PAR-18-324 (R01 - Clinical Trial Optional)

PAR-18-307 (R21/R33 Clinical Trial Optional)
January 8, 2021 Frank Perna
240-276-6782
pernafm@mail.nih.gov
Cancer-related Behavioral Research through Integrating Existing Data

Helpful Resources
PAR-16-256 (R01)
PAR-16-255 (R21)
June 15, 2019 Richard Moser
240-276-6915
moserr@mail.nih.gov
Stimulating Innovations in Behavioral Intervention Research for Cancer Prevention and Control

Helpful Resources
PAR-18-018 (R21 Clinical Trial Optional) May 8, 2019 Tanya Agurs-Collins
240-276-6956
collinsta@mail.nih.gov
Population Health Interventions: Integrating Individual and Group Level Evidence PA-18-385 (R01 Clinical Trial Optional)
PA-18-407 (R21 Clinical Trials Optional)
PA-18-356 (R01 Clinical Trials Not Allowed)
PA-18-406 (R21 Clinical Trials Not Allowed)
May 8, 2019 David Berrigan
240-276-6752 berrigad@mail.nih.gov
Obesity Policy Evaluation Research PA-16-165 (R01) May 8, 2019 David Berrigan
240-276-6752
berrigad@mail.nih.gov
Interdisciplinary Research Teams to Investigate Reciprocal Basic Behavioral and Social Linkages Between Sleep and Stress PAR-18-694 (R24 Clinical Trial Optional) November 30, 2018 Kara Hall
240-276-6831 hallka@mail.nih.gov

Todd Horowitz
240-678-5986
todd.horowitz@nih.gov

See information about NCI Small Grants Program for Cancer Research (NCI Omnibus) and NIH Research Project Grants

Title Announcement # Expiration Date Contact
End-of-Life and Palliative Care Health Literacy: Improving Outcomes in Serious, Advanced Illness PA-18-498 (R01 Clinical Trial Optional)
PA-18-499 (R21 Clinical Trial Optional)
May 8, 2021 Sylvia Chou
240-276-6954
chouws@mail.nih.gov
Cancer-related Behavioral Research through Integrating Existing Data

Helpful Resources
PAR-16-256 (R01)
PAR-16-255 (R21)
June 15, 2019 Richard Moser
240-276-6915
moserr@mail.nih.gov
Innovative Approaches to Studying Cancer Communication in the New Media Environment

Helpful Resources
PAR-18-638 (R01 Clinical Trial Optional)
PAR-18-639 (R21 Clinical Trial Optional)
June 14, 2019 Kelly Blake
240-281-5934
kelly.blake@nih.gov
Communication and Decision Making for Individuals with Inherited Cancer Syndromes RFA-CA-19-001 (U01 Clinical Trial Optional) January 10, 2019 Wendy Nelson
240-276-6971
nelsonw@mail.nih.gov
Revision Applications for Validation of Mobile/Wireless Health Tools for Measurement and Intervention PA-18-339 (R01 Clinical Trial Optional) January 8, 2019 April Oh
240-276-6709
april.oh@nih.gov
Mechanism for Time-Sensitive Drug Abuse Research PAR-18-064 (R21 Clinical Trial Optional) November 9, 2018

Kelly Blake
240-281-5934
kelly.blake@nih.gov

Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Programs at the National Institutes of Health April Oh
240-276-6709
april.oh@nih.gov
NIH Guide Notice on NIH-NSF joint funding opportunity, "Smart and Connected Health" April Oh
240-276-6709
april.oh@nih.gov

See information about NCI Small Grants Program for Cancer Research (NCI Omnibus) and NIH Research Project Grants

TCRB Funding Opportunity Announcements (PDF, 182 KB), October 2018

Title Announcement # Expiration Date Contact
Multi-Site Studies for System-Level Implementation of Substance Use Prevention and Treatment Services PAR-18-222 (R01 Clinical Trial Optional)
PAR-16-455 (R01)
November 14, 2020 Glen Morgan
240-276-6787
gmorgan@nih.gov
Electronic Nicotine Delivery Systems (ENDS): Basic Mechanisms of Health Effects PAR-18-845 (R01 Clinical Trial Not Allowed)
PAR-18-846 (R21 Clinical Trial Not Allowed)
June 28, 2020 Ron Johnson
240-276-6228 
rjohnso2@mail.nih.gov
Electronic Nicotine Delivery Systems (ENDS): Population, Clinical and Applied Prevention Research PAR-18-847 (R01 Clinical Trial Optional)
PAR-18-848 (R21 Clinical Trial Optional)
June 28, 2020 For cancer-related FOA questions:
Rachel Grana Mayne
240-276-5899
rachel.mayne@nih.gov

For general FOA questions:
Dionne C. Godette
Office of Disease Prevention (ODP)
301-480-1161
dionne.godette@nih.gov
U.S. Tobacco Control Policies to Reduce Health Disparities

Helpful Resources
PAR-18-675 (R01 Clinical Trial Optional)
PAR-18-674 (R21 Clinical Trial Optional)
June 16, 2020 Bob Vollinger
240-276-6919
bob.vollinger@nih.gov
Tobacco Use and HIV in Low and Middle Income Countries

Helpful Resources
PAR-18-023 (R01 Clinical Trial Optional)
PAR-18-022 (R21 Clinical Trial Optional)
January 8, 2020 Mark Parascandola
240-276-6871
paramark@mail.nih.gov
Target Assessment, Engagement and Data Replicability to Improve Substance Use Disorders Treatment Outcomes PAR-18-086 (R21/R33 Clinical Trial Optional)
PAR-18-085 (R33 Clinical Trial Optional)
September 8, 2019 Glen Morgan
240-276-6787
gmorgan@nih.gov
Integrative Research on Polysubstance Abuse and Addiction PAR-18-084 (R21/R33 Clinical Trial Optional) September 8, 2019 Glen Morgan
240-276-6787
gmorgan@nih.gov
Cancer-related Behavioral Research through Integrating Existing Data

Helpful Resources
PAR-16-256 (R01)
PAR-16-255 (R21)
June 15, 2019 Richard Moser
240-276-6915
moserr@mail.nih.gov
Improving Smoking Cessation in Socioeconomically Disadvantaged Populations via Scalable Interventions

Helpful Resources
PAR-18-251 (R01 Clinical Trial Optional)
PAR-18-250 (R21 Clinical Trial Optional)
June 14, 2019 Yvonne Prutzman
240-276-6975
huntym@mail.nih.gov
Accelerating the Pace of Drug Abuse Research Using Existing Data PAR-18-062 (R01 Clinical Trial Optional) May 8, 2019 Annette Kaufman
240-276-6706
kaufmana@mail.nih.gov
Tobacco Regulatory Science


Tobacco Regulatory Science Small Grant Program for New Investigators
RFA-OD-18-002 (R01 Clinical Trial Optional)
RFA-OD-18-003 (R21 Clinical Trial Optional)
RFA-OD-18-001 (R03 Clinical Trial Optional)
February 14, 2019 Rachel Grana Mayne
240-276-5899
rachel.mayne@nih.gov
Improving Smoking Cessation Interventions among People Living with HIV RFA-CA-18-027 (R01 Clinical Trial Optional)
RFA-CA-18-028 (R21 Clinical Trial Optional)
January 9, 2019 Annette Kaufman
240-276-6706
kaufmana@mail.nih.gov
Mechanism for Time-Sensitive Drug Abuse Research PAR-18-064 (R21 Clinical Trial Optional) November 9, 2018

Kelly Blake
240-281-5934
kelly.blake@nih.gov


View Current and Past Behavioral Research Grants


Other Funding Opportunities

Need Help?

Contact BRP staff by email or phone. BRP Staff Directory

Explore Funding History

DCCPS provides detailed information about funded program announcement initiatives, request for application initiatives, and trends.